Avandia Settlements: Glaxo Agrees to Pay $60 Million

Shares

GlaxoSmithKline Plc agreed to pay about $60 million in the first settlements of lawsuits alleging the company’s Avandia diabetes drug causes heart attacks and strokes in some users, according to a Bloomberg report.

Glaxo agreed to resolve more than 700 Avandia suits filed by three attorneys, including Houston-based plaintiffs’ lawyer Mark Lanier and Philadelphia-based litigator Sol Weiss. The settlements come as Glaxo is set to face its first Avandia trial in state court in Philadelphia in July.
The company faces about 4,000 lawsuits that have been filed so far over the drug.

1
Leave a Reply

avatar
3000
1 Comment threads
0 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
1 Comment authors
Allison Recent comment authors
  Subscribe  
newest oldest most voted
Notify of
Allison
Allison

And people wonder why drugs cost so much.

Copyright © 2009-2018 Diabetes Media Foundation, All Rights Reserved.
ASweetLife™ is a trademark of the Diabetes Media Foundation, All Rights Reserved.